ACADIA Pharmaceuticals Inc. Outside Director Compensation Program Description

Summary

ACADIA Pharmaceuticals Inc. has established a compensation program for its non-management directors, effective June 1, 2017. Under this program, outside directors receive an annual cash retainer of $50,000, with additional fees for serving as Board Chair or as chairs or members of key committees. Directors also receive stock options: 15,000 options upon joining the Board and 15,000 options annually thereafter. Payments and grants are made after the Board meeting following the annual stockholders' meeting, and compensation may be prorated for directors joining mid-year.

EX-10.1 2 acad-ex101_8.htm EX-10.1 acad-ex101_8.htm

Exhibit 10.1

 

ACADIA Pharmaceuticals Inc.

 

Description of Outside Director Compensation Program

 

The Board of Directors (the “Board”) of ACADIA Pharmaceuticals Inc. (“ACADIA”) has approved the following fees that are payable to the non-management directors who are members of the Board, effective June 1, 2017:

 

Annual Retainer

$50,000

Additional Retainer for Board Chair

$30,000

Additional Retainer for Audit Chair

$20,000

Additional Retainer for Audit Member (non-Chair)

$10,000

Additional Retainer for Compensation Chair

$20,000

Additional Retainer for Compensation Member (non-Chair)

$10,000

Additional Retainer for Nominating and Corporate Governance Chair

$10,000

Additional Retainer for Nominating and Corporate Governance Member (non-Chair)

$ 5,000

 

 

 

 

Options

15,000 upon joining Board

 

15,000 annual grant thereafter

 

The Annual Retainer amounts are payable following the first meeting of the Board that follows the annual meeting of ACADIA’s stockholders. Annual option grants to directors are made at the Board meeting following the annual meeting of stockholders in accordance with the provisions of stock option plans that have been approved by ACADIA’s stockholders.  The annual retainer amount may be pro- rated for a director that joins the Board other than at the first meeting of the Board following the annual meeting of stockholders.